UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
US7700285B1
(en)
|
2005-12-29 |
2010-04-20 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 immunogenic compositions and methods of producing such compositions
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
KR101347503B1
(ko)
*
|
2005-09-09 |
2014-01-02 |
인터벳 인터내셔널 비.브이. |
Pcv-2 백신
|
JP2009514839A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
サイトカイン誘導剤を含むアジュバントインフルエンザワクチン
|
JP2009514850A
(ja)
|
2005-11-04 |
2009-04-09 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
アジュバントとして減少した量の水中油型エマルションを有するインフルエンザワクチン
|
ES2792398T3
(es)
|
2005-11-04 |
2020-11-11 |
Seqirus Uk Ltd |
Vacunas adyuvantadas con antígenos de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular
|
MX338626B
(es)
|
2005-12-29 |
2016-04-26 |
Boehringer Ingelheim Vetmed |
Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
|
TWI528970B
(zh)
*
|
2005-12-29 |
2016-04-11 |
百靈佳殷格翰家畜藥品公司 |
多價第二型豬環狀病毒(pcv2)免疫組合物及製備該組合物之方法
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
KR20080100384A
(ko)
*
|
2006-03-03 |
2008-11-17 |
메리얼 리미티드 |
마이코플라즈마 하이오뉴모니아에 백신
|
EP2004226A1
(en)
|
2006-03-24 |
2008-12-24 |
Novartis Vaccines and Diagnostics GmbH & Co. KG |
Storage of influenza vaccines without refrigeration
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
US20100010199A1
(en)
|
2006-09-11 |
2010-01-14 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
US20100136060A1
(en)
*
|
2006-11-22 |
2010-06-03 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of reducing porcine circovirus-associated disease outbreaks
|
WO2008068631A2
(en)
|
2006-12-06 |
2008-06-12 |
Novartis Ag |
Vaccines including antigen from four strains of influenza virus
|
US20100129397A1
(en)
|
2006-12-11 |
2010-05-27 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
PT2481420T
(pt)
*
|
2006-12-15 |
2019-05-31 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacina para porcos anti-pcv2 de dose única
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
KR20150082667A
(ko)
|
2007-04-06 |
2015-07-15 |
인비라젠 인코포레이티드 |
살아있는 약독화된 바이러스를 위한 방법 및 조성물
|
PL2185191T3
(pl)
|
2007-06-27 |
2013-02-28 |
Novartis Ag |
Szczepionki przeciwko grypie o małej zawartości dodatków
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7829274B2
(en)
*
|
2007-09-04 |
2010-11-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Reduction of concomitant infections in pigs by the use of PCV2 antigen
|
CN101951949B
(zh)
|
2007-10-19 |
2013-10-02 |
诺华股份有限公司 |
脑膜炎球菌疫苗制剂
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
CN106562927A
(zh)
*
|
2007-12-21 |
2017-04-19 |
硕腾服务有限责任公司 |
经热处理的菌苗,及由这些经热处理的菌苗制备的乳剂疫苗
|
WO2009088950A2
(en)
*
|
2007-12-31 |
2009-07-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Pcv2 orf2 virus like particle with foreign amino acid insertion
|
CA2712006A1
(en)
*
|
2008-01-23 |
2009-10-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
|
NZ587798A
(en)
|
2008-03-18 |
2013-06-28 |
Novartis Ag |
Improvements in the preparation of influenza virus vaccine antigens utilising a phosphate buffer
|
EP2306812A4
(en)
*
|
2008-07-30 |
2013-02-20 |
Univ Kentucky Res Found |
EQUINE DISEASE MODEL FOR NEUROLOGICAL AUROPTIC VIRUS DISEASE AND USED ASSAYS
|
AU2009294318B2
(en)
|
2008-09-18 |
2014-04-24 |
Novartis Ag |
Vaccine adjuvant combinations
|
EP2367566B2
(en)
|
2008-11-28 |
2019-11-27 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant avian influenza vaccine and uses thereof
|
US20120093860A1
(en)
|
2009-02-10 |
2012-04-19 |
Novartis Ag |
Influenza vaccines with increased amounts of h3 antigen
|
DK2396032T3
(da)
|
2009-02-10 |
2016-12-19 |
Seqirus Uk Ltd |
Influenzavacciner med reducerede mængder squalen
|
AU2010212547B2
(en)
|
2009-02-10 |
2015-03-12 |
Seqirus UK Limited |
Influenza vaccine regimens for pandemic-associated strains
|
JP2012519482A
(ja)
|
2009-03-06 |
2012-08-30 |
ノバルティス アーゲー |
クラミジア抗原
|
EP2228054A1
(en)
*
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Riluzole aqueous suspensions
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
EP2419129A2
(en)
|
2009-04-14 |
2012-02-22 |
Novartis AG |
Compositions for immunising against staphylococcus aerus
|
JP5744852B2
(ja)
*
|
2009-05-19 |
2015-07-08 |
バイオプロパティーズ ピーティーワイ リミテッド |
Mycoplasmahyopneumoniaeの温度感受性ワクチン株およびその使用
|
KR101800245B1
(ko)
|
2009-05-21 |
2017-11-22 |
노파르티스 아게 |
비-내인성 pol i 프로모터를 사용하는 역 유전학
|
JP5823379B2
(ja)
|
2009-05-29 |
2015-11-25 |
ノバルティス アーゲー |
インフルエンザウイルスヘマグルチニンについてのアッセイ
|
EP2451833B1
(en)
|
2009-07-07 |
2018-01-17 |
GlaxoSmithKline Biologicals SA |
Conserved escherichia coli immunogens
|
EP2464658B1
(en)
|
2009-07-16 |
2014-10-01 |
Novartis AG |
Detoxified escherichia coli immunogens
|
RU2558257C2
(ru)
*
|
2009-07-31 |
2015-07-27 |
Нэшнл Рисерч Каунсл Оф Канада |
ВНЕШНИЙ КОРОВОЙ ЭПИТОП ЛИПОПОЛИСАХАРИДА Н. pylori
|
AR078253A1
(es)
|
2009-09-02 |
2011-10-26 |
Boehringer Ingelheim Vetmed |
Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
|
BR112012008338A2
(pt)
|
2009-09-10 |
2019-09-24 |
Novartis Ag |
combinação de vacinas contra doenças do trato respiratório.
|
CA2773486C
(en)
*
|
2009-09-10 |
2017-10-10 |
Merial Limited |
New vaccine formulations comprising saponin-containing adjuvants
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
AU2010302344A1
(en)
|
2009-09-30 |
2012-04-26 |
Novartis Ag |
Expression of meningococcal fhbp polypeptides
|
EP2491117B2
(en)
|
2009-10-20 |
2017-06-28 |
Novartis AG |
Improved reverse genetics methods for virus rescue
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
CA2793510A1
(en)
|
2010-03-18 |
2012-02-16 |
Novartis Ag |
Adjuvanted vaccines for serogroup b meningococcus
|
FR2957933B1
(fr)
*
|
2010-03-24 |
2012-04-27 |
Seppic Sa |
Vaccin vivant pour maladies aviaires
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
EP2556151A1
(en)
|
2010-04-07 |
2013-02-13 |
Novartis AG |
Method for generating a parvovirus b19 virus-like particle
|
US9555093B2
(en)
|
2010-04-30 |
2017-01-31 |
Temasek Life Sciences Laboratory Limited |
Universal vaccine against H5N1 lineages
|
PL2569007T3
(pl)
|
2010-05-11 |
2016-04-29 |
Intervet Int Bv |
Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
|
CN103025350A
(zh)
|
2010-05-21 |
2013-04-03 |
诺华有限公司 |
流感病毒的重配方法
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
WO2011161653A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
EP3153578A1
(en)
|
2010-07-06 |
2017-04-12 |
Novartis Ag |
Norovirus derived immunogenic compositions and methods
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
TR201811280T4
(tr)
|
2011-03-02 |
2018-08-27 |
Glaxosmithkline Biologicals Sa |
Düşük antijen ve/ veya adjuvan dozları olan karma aşılar.
|
EP2736921B1
(en)
|
2011-07-25 |
2018-06-27 |
GlaxoSmithKline Biologicals SA |
Compositions and methods for assessing functional immunogenicity of parvovirus vaccines
|
ES2732708T3
(es)
|
2011-09-14 |
2019-11-25 |
Glaxosmithkline Biologicals Sa |
Procedimientos de fabricación de glucoconjugados de sacárido-proteína
|
EP2768528A1
(en)
|
2011-10-20 |
2014-08-27 |
Novartis AG |
Adjuvanted influenza b virus vaccines for pediatric priming
|
WO2013088367A1
(en)
|
2011-12-12 |
2013-06-20 |
Novartis Ag |
Assay for influenza virus hemagglutinins
|
CN104023744A
(zh)
|
2011-12-23 |
2014-09-03 |
诺华股份有限公司 |
用于针对金黄色葡萄球菌免疫的稳定组合物
|
AU2013221479B2
(en)
*
|
2012-02-14 |
2017-06-08 |
Boehringer Ingelheim Animal Health USA Inc. |
Rotavirus subunit vaccines and methods of making and use thereof
|
AU2013205478B9
(en)
|
2012-03-02 |
2014-11-20 |
Seqirus UK Limited |
Influenza virus reassortment
|
JP2015526062A
(ja)
|
2012-06-04 |
2015-09-10 |
ノバルティス アーゲー |
改善された安全性試験
|
US20150203543A1
(en)
|
2012-08-31 |
2015-07-23 |
Novartis Ag |
Stabilised proteins for immunising against staphylococcus aureus
|
EP2890394B1
(en)
|
2012-08-31 |
2019-05-01 |
GlaxoSmithKline Biologicals SA |
Stabilised proteins for immunising against staphylococcus aureus
|
WO2014039978A2
(en)
|
2012-09-10 |
2014-03-13 |
Szathmary Dr Susan |
Vaccine to prevent mycoplasmal infection in waterfowl
|
CA2882382A1
(en)
|
2012-09-18 |
2014-03-27 |
Novartis Ag |
Outer membrane vesicles
|
EA201590427A1
(ru)
|
2012-10-02 |
2015-09-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Нелинейные сахаридные конъюгаты
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
AU2013351182C1
(en)
|
2012-11-30 |
2018-11-08 |
Glaxosmithkline Biologicals Sa |
Pseudomonas antigens and antigen combinations
|
WO2014086732A2
(en)
|
2012-12-03 |
2014-06-12 |
Novartis Ag |
Influenza virus reassortment
|
BR112015021880A2
(pt)
|
2013-03-13 |
2017-09-26 |
Novartis Ag |
rearranjo de vírus influenza b
|
ES2882374T3
(es)
|
2013-05-08 |
2021-12-01 |
Pharmgate Biologics Inc |
Vacuna para PCV2 y micoplasma
|
CN105828835A
(zh)
|
2013-05-10 |
2016-08-03 |
诺华股份有限公司 |
避免流感疫苗中的发作性嗜睡病风险
|
DE202013005100U1
(de)
|
2013-06-05 |
2013-08-26 |
Novartis Ag |
Influenza Virus Reassortierung
|
DE202013005130U1
(de)
|
2013-06-05 |
2013-09-10 |
Novartis Ag |
Influenza Virus Reassortierung
|
AU2014276418A1
(en)
|
2013-06-06 |
2016-01-21 |
Novartis Ag |
Influenza virus reassortment
|
AU2014329524B2
(en)
|
2013-10-02 |
2019-01-17 |
Boehringer Ingelheim Animal Health USA Inc. |
PCV2 ORF2 protein variant and virus like particles composed thereof
|
CA2931137C
(en)
*
|
2013-12-03 |
2023-03-14 |
Intervet International B.V. |
Vaccine against porcine circo virus type 2
|
CN103751779A
(zh)
*
|
2014-02-25 |
2014-04-30 |
中国农业科学院上海兽医研究所 |
O型口蹄疫多肽的泊洛沙姆凝胶佐剂
|
EA037818B1
(ru)
|
2014-03-26 |
2021-05-25 |
Глаксосмитклайн Байолоджикалс С.А. |
Мутантные стафилококковые антигены
|
US9713639B2
(en)
|
2014-05-19 |
2017-07-25 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
|
US20150359880A1
(en)
*
|
2014-06-16 |
2015-12-17 |
Biomune Company |
Dual adjuvant vaccine compositions, preparation and uses
|
CN105267962A
(zh)
*
|
2014-06-18 |
2016-01-27 |
潘皓 |
纳米乳疫苗辅剂
|
JP2015120709A
(ja)
*
|
2015-01-09 |
2015-07-02 |
ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex,S.A. De C.V. |
遺伝子組み換え不活性化ウィルスベクターワクチン
|
WO2016210083A2
(en)
|
2015-06-26 |
2016-12-29 |
Merial, Inc. |
Inactivated canine influenza vaccines and methods of making and uses thereof
|
EP3313439A2
(en)
|
2015-06-26 |
2018-05-02 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
KR102576962B1
(ko)
|
2015-07-07 |
2023-09-11 |
세퀴러스 유케이 리미티드 |
인플루엔자 효능 검정
|
JP6986019B2
(ja)
|
2015-10-08 |
2021-12-22 |
ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド |
レプトスピラ用生弱毒化異種ワクチン
|
MA49414A
(fr)
|
2015-11-23 |
2020-04-22 |
Boehringer Ingelheim Animal Health Usa Inc |
Protéines de fusion de dmdv et e2 et leurs utilisations
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
JP7174698B2
(ja)
*
|
2016-11-29 |
2022-11-17 |
インターベット インターナショナル ベー. フェー. |
ブタワクチン
|
EP4112072A1
(en)
|
2016-12-14 |
2023-01-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
|
FR3092754B1
(fr)
*
|
2019-02-18 |
2022-06-03 |
Total Marketing Services |
Composition adjuvante pour vaccin
|
US20230000971A1
(en)
|
2019-11-18 |
2023-01-05 |
Seqirus Pty Ltd. |
Method for producing reassortant influenza viruses
|
CN113546162B
(zh)
*
|
2021-05-31 |
2023-07-18 |
江苏省农业科学院 |
一种支原体疫苗及其制备方法
|